Compound Evidence File
#EC-2026-0200
Thymalin
Filed under Peptides. The bureau holds 170 laboratory returns for this compound from 64 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
64 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 10.0 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 10.0 | 10.0 | 25 Jan 2026 | 17 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 10.0 | 10.0 | 2 May 2026 | 11 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Apr 2026 | 25 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 21 Dec 2025 | 21 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 22 Nov 2025 | 18 Mar 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 10.0 | 10.0 | 15 Dec 2025 | 21 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 7 Jan 2026 | 17 Feb 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Mar 2026 | 26 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Jan 2026 | 14 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Feb 2026 | 24 Feb 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 2 Jan 2026 | 23 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 10.0 | 10.0 | 10.0 | 26 Jan 2026 | 5 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 10.0 | 10.0 | 10.0 | 12 Apr 2026 | 21 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 10.0 | 10.0 | 10.0 | 12 Dec 2025 | 21 May 2026 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 | 2 Apr 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 18 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 9.9 | 15 Apr 2026 | 9 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 9.9 | 9.9 | 10.0 | 17 Mar 2026 | 28 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 10 Apr 2026 | 1 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 27 Apr 2026 | 9 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 24 Mar 2026 | 18 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 10 Jul 2026 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 9.6 | 9.6 | 9.6 | 24 Apr 2025 | 24 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 9.1 | 7.3 | 10.0 | 23 May 2026 | 23 May 2026 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 9.0 | 9.0 | 9.0 | 3 Jul 2025 | 3 Jul 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 9.0 | 9.0 | 9.0 | 13 Feb 2025 | 13 Feb 2025 |
| Bfflist AMOCASE #VI-2026-0678 | X | 2 | 8.9 | 8.3 | 9.6 | 24 Apr 2025 | 19 Jan 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 8.9 | 8.9 | 8.9 | 27 Feb 2025 | 27 Feb 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.8 | 7.5 | 10.0 | 25 May 2026 | 25 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 8.7 | 8.7 | 8.7 | 20 Jun 2025 | 20 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 8.6 | 7.8 | 9.3 | 21 May 2026 | 21 May 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 8.6 | 8.6 | 8.6 | 7 May 2025 | 7 May 2025 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 8.4 | 8.4 | 8.4 | 7 May 2025 | 7 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.3 | 7.0 | 9.4 | 23 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.3 | 7.5 | 9.4 | 21 May 2026 | 21 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 7.7 | 7.7 | 7.7 | 2 Jul 2025 | 2 Jul 2025 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 8 | 7.6 | 4.5 | 10.0 | 24 Apr 2025 | 26 Jan 2026 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 2 | 7.0 | 6.9 | 7.1 | 8 Jul 2025 | 24 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 7.0 | 7.0 | 7.0 | 3 Jul 2025 | 3 Jul 2025 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 6.9 | 5.8 | 8.0 | 27 Feb 2025 | 24 May 2026 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 6.9 | 6.9 | 6.9 | 3 Jul 2025 | 3 Jul 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 6.8 | 6.8 | 6.8 | 3 Jul 2025 | 3 Jul 2025 |
| UtherCASE #VI-2026-0902 | X | 5 | 6.7 | 5.0 | 8.3 | 13 Jun 2025 | 21 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 6.6 | 6.6 | 6.6 | 9 Jun 2025 | 9 Jun 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 9 | 6.4 | 4.0 | 10.0 | 3 Jun 2025 | 21 May 2026 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 6.3 | 6.3 | 6.3 | 2 Jul 2025 | 2 Jul 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 4 | 6.1 | 5.2 | 8.1 | 13 Jun 2025 | 26 Jan 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 6.0 | 6.0 | 6.0 | 3 Jul 2025 | 3 Jul 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 5.9 | 5.9 | 5.9 | 2 Apr 2025 | 2 Apr 2025 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 5.8 | 5.8 | 5.8 | 27 Feb 2025 | 27 Feb 2025 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 5.8 | 5.8 | 5.8 | 24 Apr 2025 | 24 Apr 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 5.7 | 3.8 | 7.5 | 3 Jun 2025 | 21 May 2026 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 5.7 | 5.7 | 5.7 | 13 Feb 2025 | 13 Feb 2025 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 | 13 Feb 2025 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 5.2 | 5.2 | 5.2 | 16 Mar 2025 | 16 Mar 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 3 | 4.6 | 3.6 | 5.6 | 24 Apr 2025 | 20 May 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 1 | 4.5 | 4.5 | 4.5 | 13 Feb 2025 | 13 Feb 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 3.6 | 3.6 | 3.6 | 7 May 2025 | 7 May 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 3.1 | 3.1 | 3.1 | 21 May 2025 | 21 May 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 1.7 | 1.7 | 1.7 | 13 Feb 2025 | 13 Feb 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 1.2 | 1.2 | 1.2 | 20 Jun 2025 | 20 Jun 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.8 | 0.8 | 0.8 | 8 Jul 2025 | 8 Jul 2025 |
Open any subject to view the batch-level evidence for Thymalin alone.